English
| dc.contributor.author | Cetin, M | |
| dc.contributor.author | Yildirimer, M | |
| dc.contributor.author | Özen, S | |
| dc.contributor.author | Tanriverdi, S | |
| dc.contributor.author | Coskun, S | |
| dc.date.accessioned | 2024-07-18T11:55:55Z | |
| dc.date.available | 2024-07-18T11:55:55Z | |
| dc.description.abstract | HINDAWI LTD | |
| dc.identifier.issn | 1687-9635 | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6576 | |
| dc.language.iso | Article | |
| dc.publisher | 1687-9627 | |
| dc.subject | Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia. | |
| dc.title | English |